Atlas Trials

Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia

Clinical trial NCT04409041 · COMPLETED

Trial details

NCT number
NCT04409041
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lichen PlanopilarisFrontal Fibrosing Alopecia
Start date
2019-09-01
Primary completion
2020-12-31
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.